Literature DB >> 35223271

Parvovirus b19-Induced Acute Hepatitis With Hepatosplenomegaly and Polyarthropathy.

Ubaid Khan1, Rana Uzair Ahmad2,3, Zabeeh Ullah2, Tooba Fida4, Muhammad Shehryar3.   

Abstract

Parvovirus B19 infection can present with myriads of clinical diseases and syndromes; hepatitis and polyarthropathy are a few of these examples. Parvovirus frequently affects children but this condition has also been reported in adults.  The present case report discusses a case of a 43-year-old female who presented to the outpatient department (OPD) with complaints of high-grade fever and pain in multiple joints of her body for three days. On examination, stiffness and swelling of the hand, knees, wrist, and ankles were noted. Laboratory investigations showed highly elevated aspartate transaminase (AST), alanine transaminase (ALT), and bilirubin. Electrocardiogram (ECG) and echocardiogram (ECHO) findings were unremarkable. PCR testing showed the presence of parvovirus. Parvovirus B19 infection led to the development of acute hepatitis, which appeared as yellowing of skin (jaundice) and led to hepatosplenomegaly. Parvovirus-induced polyarthropathy was also observed in the patient. The patient was managed with a parenteral course of ceftriaxone, paracetamol, and a normal saline infusion. Anti-viral drugs were also prescribed to the patient including ribavirin and pegylated interferon. This case study will explore how the patient was diagnosed and managed with conventional therapy and anti-viral to relieve parvovirus-induced hepatitis with hepatosplenomegaly and polyarthritis. Acute hepatitis can be caused by viruses and other noninfectious causes, all of which must be cleared out to avoid chronic disease development. When patients present with joint pain and skin rashes, a thorough workup for viral indicators, medication histories, autoimmune and metabolic illnesses, and parvovirus b19 infection is required.
Copyright © 2022, Khan et al.

Entities:  

Keywords:  acute hepatitis; hepatosplenomegaly; parovirus induced hepatitis; parvovirus b19; polyarthropathy

Year:  2022        PMID: 35223271      PMCID: PMC8860716          DOI: 10.7759/cureus.21494

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Parvovirus B19 infection in pregnancy.

Authors:  Joan Crane; William Mundle; Isabelle Boucoiran
Journal:  J Obstet Gynaecol Can       Date:  2014-12

3.  Acute hepatitis as a manifestation of parvovirus B19 infection.

Authors:  Aleisha Hatakka; Julianne Klein; Runtao He; Jessica Piper; Edward Tam; Andrew Walkty
Journal:  J Clin Microbiol       Date:  2011-07-06       Impact factor: 5.948

4.  Human parvovirus B19 infection associated with acute hepatitis.

Authors:  Y Yoto; T Kudoh; K Haseyama; N Suzuki; S Chiba
Journal:  Lancet       Date:  1996-03-30       Impact factor: 79.321

5.  Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients.

Authors:  W C Koch; G Massey; C E Russell; S P Adler
Journal:  J Pediatr       Date:  1990-03       Impact factor: 4.406

Review 6.  Human parvovirus B19 infection in organ transplant recipients.

Authors:  S Marchand; G Tchernia; C Hiesse; G Tertian; J Cartron; F Kriaa; S Boubenider; C Goupy; D Lecointe; B Charpentier
Journal:  Clin Transplant       Date:  1999-02       Impact factor: 2.863

7.  Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies.

Authors:  K McClain; Z Estrov; H Chen; D H Mahoney
Journal:  Br J Haematol       Date:  1993-09       Impact factor: 6.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.